Title

ProAmatine (Midodrine Hydrochloride) Tablets
Company:  Shire Laboratories Inc.
Application No.:  19-815/S5
Approval Date: 3/20/2002

• Approval Letter(s)  

• Printed Labeling  

• Chemistry Review(s)  

• Clinical Pharmacology Biopharmaceutics Review(s)  

• Correspondence  

Back to Drug Approval Page

Some documents are in Portable Document Format (PDF) to retain the original format. To view or print these documents, you must use the Adobe Acrobat viewer. Acrobat is free and available directly from Adobe's website with full installation instructions.

FDA/Center for Drug Evaluation and Research
Last Updated: May 14, 2002
Originator: OTCOM/DLIS
HTML by Ej